Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic

Introduction: OnabotulinumtoxinA (BT-A) is a preventive treatment for chronic migraine (CM), which needs to be administered regularly by a trained clinician every 3 months. The spread of the severe acute respiratory syndrome coronavirus-2 pandemic has forced many patients to momentarily stop the sch...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraldi, Carlo, Ornello, Raffaele, Favoni, Valentina, Sacco, Simona, Caponnetto, Valeria, Pierangeli, Giulia, Pani, Luca, Cevoli, Sabina, Guerzoni, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082239/
https://www.ncbi.nlm.nih.gov/pubmed/33935945
http://dx.doi.org/10.3389/fneur.2021.647995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082239/
https://www.ncbi.nlm.nih.gov/pubmed/33935945
http://dx.doi.org/10.3389/fneur.2021.647995

Ejemplares similares